Pruritus Clinical Trial
Official title:
Scalp Pruritus Measurement Using Visual Analog Scale and 5-d Itch Scale in Children With Pediculosis Capitis
Pediculosis capitis is a parasitic infestation that can cause scalp pruritus and quality of
life disturbances. There are two objective measurement for pruritus, visual analog scale
(VAS) and 5-D itch scale, which can assess the severity of the scalp pruritus and the latter
can also asses the quality of life affected by pruritus. Even though VAS can not be used to
evaluate the impact of pruritus on quality of life, it is very easy to use while 5-D itch
scale is complex and not child-friendly.
The aim of this study is to determine the relationship between two different pruritus scales
and to establish validity of pruritus VAS scale in evaluating quality of life in children
with pediculosis capitis. We compare two pruritus scale on students with pediculosis of two
boarding school in Bogor, West Java, Indonesia.
This study used cross sectional design study.
Subjects with eligible criteria were included and informed consent from the parents or legal
guardian were obtained.
The diagnosis of pediculosis capitis was made based on the findings of eggs, larva, or an
adult parasite on the scalp or in the hair of the students. All subjects were asked for both
VAS and 5-D itch scale.The VAS is categorized into five groups based on the point, as
follows: 0 for no pruritus, <3 for mild pruritus, ≥ 3 - <7 for moderate pruritus, ≥ 7 - <9
for severe pruritus, and ≥ 9 for very severe pruritus. The 5-D itch scale consists of five
parameters: duration, degree, direction, disability (sleep, leisure/social activities,
housework/errands, work/school), and distribution of the pruritus with points ranging from
one to five.
Data were recorded for statistical analysis, a chi-square test was used to determine the
relationship between two categorical variables. The correlation coefficient between the VAS
and 5-D itch scale was calculated using Spearman's rank correlation
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05038982 -
Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin
|
Phase 2 | |
| Completed |
NCT04510090 -
Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic Pruritus
|
Phase 1 | |
| Completed |
NCT02143973 -
Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus
|
Phase 2/Phase 3 | |
| Terminated |
NCT01825655 -
Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching
|
Phase 4 | |
| Completed |
NCT01236859 -
Gabapentin for Prophylaxis Intrathecal Morphine-Induced Pruritus
|
N/A | |
| Completed |
NCT00782054 -
Evaluation of Post Burn Rehabilitation Population for Itch Control
|
Phase 4 | |
| Completed |
NCT04999787 -
A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With Pruritus
|
Phase 2 | |
| Recruiting |
NCT04256759 -
Dupilumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus
|
Phase 2 | |
| Completed |
NCT04337073 -
The Effect of Propofol on Dexamethasone-induced Perineal Pruritus
|
Early Phase 1 | |
| Active, not recruiting |
NCT05525520 -
Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis
|
Phase 2 | |
| Recruiting |
NCT03340155 -
Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases
|
N/A | |
| Completed |
NCT04399525 -
Influence of H1-antihistamines on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.
|
N/A | |
| Recruiting |
NCT02432508 -
Efficacy of Laser Acupuncture on Pruritus in Patients With Chronic Kidney Disease Undergoing Hemodialysis
|
N/A | |
| Completed |
NCT02653703 -
L-menthol as a Topical Counter-irritant to TRPA1-induced Neurogenic Inflammation and Pain
|
N/A | |
| Completed |
NCT01963793 -
Topical Aprepitant in Prurigo Patients
|
Phase 2 | |
| Completed |
NCT01232985 -
Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults
|
Phase 2 | |
| Not yet recruiting |
NCT00577967 -
Gabapentin - A Solution to Uremic Pruritus?
|
N/A | |
| Recruiting |
NCT06120907 -
Swiss Itch Registry
|
||
| Recruiting |
NCT04589429 -
Adding Nalbuphine for Control of Intrathecal Morphine Pruritus
|
Phase 2 | |
| Completed |
NCT03322137 -
Safety, Efficacy, and Tolerability of SNA-120 in Subjects With Pruritus Associated With Psoriasis Vulgaris
|
Phase 2 |